SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 32 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$44,000
+22.2%
41,574
-3.1%
0.00%0.0%
Q4 2021$36,000
-54.4%
42,900
-27.9%
0.00%0.0%
Q3 2021$79,000
-37.3%
59,500
-10.0%
0.00%
-50.0%
Q2 2021$126,00066,1000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders